Baishan Jiang, Ph.D
Affiliations: | 2015- | Harvard Medical School/Dana-Farber Cancer Institute, Boston, MA, United States |
Google:
"Baishan Jiang"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jiang B, Wang ES, Donovan KA, et al. (2019) Development of dual and selective degraders of cyclin-dependent kinases 4 and 6. Angewandte Chemie (International Ed. in English) |
| Brand M, Jiang B, Bauer S, et al. (2018) Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML. Cell Chemical Biology |
| Browne CM, Jiang B, Ficarro SB, et al. (2018) A Chemoproteomic Strategy for Direct and Proteome-wide Covalent Inhibitor Target-site Identification. Journal of the American Chemical Society |
| Olson CM, Jiang B, Erb MA, et al. (2017) Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. Nature Chemical Biology |
| Huang HT, Seo HS, Zhang T, et al. (2017) MELK is not necessary for the proliferation of basal-like breast cancer cells. Elife. 6 |
| Johannessen L, Sundberg TB, O'Connell DJ, et al. (2017) Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. Nature Chemical Biology |